AbbVie’s new AI deal; Roche’s PhIII win in breast cancer; SpringWorks to raise $275Mnews2023-12-05T16:15:47+00:00December 5th, 2023|Endpoints News|
Obesity deals come into focus after Roche shells out $2.7B for Carmotnews2023-12-05T16:02:26+00:00December 5th, 2023|Endpoints News|
Scoop: Infex eyes $25M Series A to advance antibody for chronic lung infectionnews2023-12-05T15:38:59+00:00December 5th, 2023|Endpoints News|
Bausch Health’s Salix initiates first awareness day for opioid-induced constipationnews2023-12-05T14:56:04+00:00December 5th, 2023|Endpoints News|
Boehringer looks ‘beyond stable’ to display the everyday realities of life with schizophrenianews2023-12-05T14:43:21+00:00December 5th, 2023|Endpoints News|
BIO names its vice chair and Amicus founder John Crowley as next CEOnews2023-12-05T13:37:44+00:00December 5th, 2023|Endpoints News|
Lilly’s Verzenio just misses the mark on overall survival in PhIII breast cancer studynews2023-12-05T13:15:40+00:00December 5th, 2023|Endpoints News|
Travere plans to lay off 20% of workforce as it focuses on full approval for kidney disease drugnews2023-12-05T12:23:43+00:00December 5th, 2023|Endpoints News|
J&J promises 20 new drugs to back pharma growth through end of decadenews2023-12-05T12:15:55+00:00December 5th, 2023|Endpoints News|
SVB report finds funding for women’s health startups is up more than 300% since 2018news2023-12-05T12:01:50+00:00December 5th, 2023|Endpoints News|
